Summit TherapeuticsSMMT
Summit Therapeutics on podcasts: where it advertises, what it's offering listeners, and what hosts say about it when they're not being paid.
Sponsorships
No ad reads on tracked podcasts in the last 30 days. Hosts are talking about it anyway — see the earned side.
What hosts are saying
Most mentioned on
In their words
“Astroenica has just invested $2 billion in a US biotech called Summit Therapeutics and they are collaborating on a really promising new cancer medicine. Some people believe that it's the biggest thing that's going to happen since Merc brought this drug to market.”
The company is described as having a promising cancer medicine with interesting data that has attracted significant investment from a major pharma company.
▶ Hear it“They signed $2 billion equity investment in Summit Therapeutics. That's one angle that's a little bit different to the usual partnership deals that you see...there is a very divided world out there on this particular drug, on this particular class of drugs.”
Company is discussed substantively regarding its bispecific antibody drug development and AstraZeneca's investment, with mixed market opinion on the technology.
▶ Hear it“Summit Therapeutics, ticker SMMT shares are rallying as much as 23%... Astroenica agreed to invest $2 billion in Summit Therapeutics to collaborate on a promising new cancer medication.”
Shares are rallying as much as 23% following a $2 billion investment agreement from AstraZeneca for cancer medication collaboration.
▶ Hear itThe full picture
A weekly email with where each one advertised and what hosts said about them. Free.